ArticleCurrent treatment options in neurology2004
Insecticides.
Article in Current treatment options in neurology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 10 citations in OpenAlex.
- Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats.British journal of pharmacology · 2014Article
- Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in African pygmy hedgehog (Atelerix albiventris).Parasites & vectors · 2012Article
- A study of neurologic symptoms on exposure to organophosphate pesticides in the children of agricultural workers.Indian journal of occupational and environmental medicine · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organophosphate (OP) insecticide toxicity is the leading cause of major morbidity and death in the insecticides class. The clinical syndrome of OP toxicity varies widely, ranging from the classic cholinergic syndrome to flaccid paralysis and intractable seizures. The mainstays of therapy for OP-poisoned patients are atropine, pralidoxime, and benzodiazepines. Tachycardia is not a contraindication to treatment with atropine in OP toxicity. Atropine should be administered to alleviate respiratory distress, symptomatic bradycardia, and as an adjunct to benzodiazepines to alleviate seizure activity. Atropine should not be administered systemically to alleviate miosis. In acute OP toxicity, a continuous pralidoxime infusion should be considered. Intermediate syndrome and OP-induced delayed neuropathy may occur in select patients with OP poisoning.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.